v3.25.2
Schedule of Summary of Consolidated Net Loss (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]        
Revenues $ 29,000 $ 43,000 $ 420,000
Operating expenses:        
Research and development 822,000 2,802,000 6,655,000 19,155,000
Total operating expenses 5,036,000 4,384,000 12,047,000 25,873,000
Operating loss (5,036,000) (4,355,000) (12,004,000) (25,453,000)
Total other income (expense), net 4,955,000 55,000 10,000 (98,000)
Loss before taxes (81,000) (4,300,000) (11,994,000) (25,551,000)
Income tax benefit (1,354,000) (782,000) (2,996,000)
Net loss $ (81,000) $ (2,946,000) (11,212,000) (22,555,000)
Single Reportable Segment [Member]        
Segment Reporting Information [Line Items]        
Revenues     43,000 420,000
Operating expenses:        
Research and development     6,655,000 19,155,000
General and administrative     5,392,000 6,718,000
Total operating expenses     12,047,000 25,873,000
Operating loss     (12,004,000) (25,453,000)
Total other income (expense), net     10,000 (98,000)
Loss before taxes     (11,994,000) (25,551,000)
Income tax benefit     (782,000) (2,996,000)
Net loss     $ (11,212,000) $ (22,555,000)